Replimune Group (REPL) has secured an agreement with the FDA to resubmit its melanoma drug application following two consecutive rejections, although shares continue trading more than 75% below pre-rejection highs. The biotechnology firm’s RP1 therapy addresses advanced...
Draft documents reviewed by Reuters reveal that the European Union is developing stringent requirements for cloud computing services in critical government...
Amazon (AMZN) revealed Tuesday its plans to broaden its lightning-fast Amazon Now delivery platform across numerous U.S. metropolitan areas, providing 30-minute delivery options...
Masayoshi Son, the founder of SoftBank Group (9984.T), is weighing a massive $100 billion investment opportunity in France targeting AI data centers, building on his recent substantial...
Alphabet’s Google (GOOG) presented policy modifications to European Union regulators on Friday, aiming to prevent substantial antitrust penalties related to its site reputation...
Qualcomm (QCOM) surged 12% in premarket trading Monday following analyst reports detailing a partnership with OpenAI to create smartphone AI processing chips. This collaboration...
Medical device manufacturer Medtronic (MDT) announced Monday that a recent cyberattack targeting its IT infrastructure did not disrupt business operations or compromise patient...
